Ahilanandan Dushianthan

7.1k total citations
69 papers, 1.3k citations indexed

About

Ahilanandan Dushianthan is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Epidemiology. According to data from OpenAlex, Ahilanandan Dushianthan has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 20 papers in Critical Care and Intensive Care Medicine and 16 papers in Epidemiology. Recurrent topics in Ahilanandan Dushianthan's work include Respiratory Support and Mechanisms (29 papers), COVID-19 Clinical Research Studies (14 papers) and Neonatal Respiratory Health Research (12 papers). Ahilanandan Dushianthan is often cited by papers focused on Respiratory Support and Mechanisms (29 papers), COVID-19 Clinical Research Studies (14 papers) and Neonatal Respiratory Health Research (12 papers). Ahilanandan Dushianthan collaborates with scholars based in United Kingdom, United States and South Africa. Ahilanandan Dushianthan's co-authors include Michael P. W. Grocott, Rebecca Cusack, Anthony D. Postle, Kathy Rowan, Michael G. Mythen, Mark Hamilton, David A Harrison, Victoria Goss, Kordo Saeed and Philip C. Calder and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ahilanandan Dushianthan

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahilanandan Dushianthan United Kingdom 18 496 360 264 247 217 69 1.3k
Sirak Petros Germany 23 384 0.8× 324 0.9× 166 0.6× 194 0.8× 213 1.0× 94 1.6k
Argirios Ε. Tsantes Greece 24 405 0.8× 274 0.8× 285 1.1× 441 1.8× 472 2.2× 104 1.9k
Rebecca Cusack United Kingdom 14 383 0.8× 248 0.7× 134 0.5× 193 0.8× 188 0.9× 40 1.1k
Kaoru Koike Japan 21 410 0.8× 374 1.0× 130 0.5× 182 0.7× 345 1.6× 76 1.5k
Jong Deog Lee South Korea 19 742 1.5× 182 0.5× 179 0.7× 97 0.4× 209 1.0× 74 1.3k
Roelie M. Wösten‐van Asperen Netherlands 18 370 0.7× 152 0.4× 135 0.5× 95 0.4× 250 1.2× 43 1.0k
Juan Carlos Q. Velez United States 21 301 0.6× 523 1.5× 227 0.9× 85 0.3× 257 1.2× 82 1.7k
Nick Anas United States 28 892 1.8× 414 1.1× 137 0.5× 211 0.9× 958 4.4× 52 2.1k
Michele Costigan United States 5 256 0.5× 398 1.1× 182 0.7× 471 1.9× 1.2k 5.3× 7 1.7k
Woon Yong Kwon South Korea 21 149 0.3× 225 0.6× 87 0.3× 252 1.0× 405 1.9× 88 1.2k

Countries citing papers authored by Ahilanandan Dushianthan

Since Specialization
Citations

This map shows the geographic impact of Ahilanandan Dushianthan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahilanandan Dushianthan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahilanandan Dushianthan more than expected).

Fields of papers citing papers by Ahilanandan Dushianthan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahilanandan Dushianthan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahilanandan Dushianthan. The network helps show where Ahilanandan Dushianthan may publish in the future.

Co-authorship network of co-authors of Ahilanandan Dushianthan

This figure shows the co-authorship network connecting the top 25 collaborators of Ahilanandan Dushianthan. A scholar is included among the top collaborators of Ahilanandan Dushianthan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahilanandan Dushianthan. Ahilanandan Dushianthan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, L. A., et al.. (2025). Lung Ultrasound in Critical Care: A Narrative Review. Diagnostics. 15(6). 755–755. 3 indexed citations
2.
Dushianthan, Ahilanandan, Rebecca Cusack, Victoria Goss, et al.. (2024). In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome. Cells. 13(4). 332–332.
3.
Goss, Victoria, Ahilanandan Dushianthan, Jenni McCorkell, et al.. (2024). Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation. International Journal of Molecular Sciences. 25(19). 10480–10480. 1 indexed citations
4.
Young, David, Cathrine McKenzie, Sanjay Gupta, et al.. (2024). Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU). Pathogens. 13(11). 961–961. 1 indexed citations
5.
Madsen, Jens, Howard Clark, Ahilanandan Dushianthan, et al.. (2024). Towards quantifying biomarkers for respiratory distress in preterm infants: Machine learning on mid infrared spectroscopy of lipid mixtures. Talanta. 275. 126062–126062. 2 indexed citations
6.
Dushianthan, Ahilanandan, Michael P. W. Grocott, Ganapathy Senthil Murugan, Tom Wilkinson, & Anthony D. Postle. (2023). Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions. Diagnostics. 13(18). 2964–2964. 21 indexed citations
7.
Dushianthan, Ahilanandan, et al.. (2023). Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia. SHILAP Revista de lepidopterología. 11(4). 70–70. 7 indexed citations
8.
Poole, Stephen, et al.. (2022). Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses. The Clinical Respiratory Journal. 16(4). 301–308. 8 indexed citations
9.
Poole, Stephen, Vasanth V Naidu, Florina Borca, et al.. (2022). Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial. Journal of Infection. 85(6). 625–633. 33 indexed citations
10.
Jackson, Alexander, et al.. (2022). Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study. PLoS ONE. 17(6). e0269471–e0269471. 3 indexed citations
11.
Moyses, Helen, Kordo Saeed, Paul R. Afolabi, et al.. (2022). Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon. Clinical Nutrition ESPEN. 51. 377–384. 5 indexed citations
12.
Cusack, Rebecca, Andrew Bates, Kay Mitchell, et al.. (2022). Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial. BMJ Open. 12(4). e055285–e055285. 1 indexed citations
13.
Dushianthan, Ahilanandan, Andrew F. Cumpstey, Matteo Ferrari, et al.. (2021). Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey. Journal of the Intensive Care Society. 23(3). 285–292. 6 indexed citations
14.
Baker, Laurence H., Buddhini Samaraweera, Adhyana I. K. Mahanama, et al.. (2021). Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?. Infezioni in Medicina. 29(3). 386–392. 1 indexed citations
15.
Jackson, Alexander, et al.. (2020). Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit. Journal of Global Antimicrobial Resistance. 22. 782–784. 43 indexed citations
16.
Grocott, Michael P. W., Ahilanandan Dushianthan, Mark Hamilton, et al.. (2013). Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review. British Journal of Anaesthesia. 111(4). 535–548. 130 indexed citations
17.
Dushianthan, Ahilanandan, et al.. (2012). Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome: Where do we go from here?. UCL Discovery (University College London). 1 indexed citations
18.
Dushianthan, Ahilanandan, Rebecca Cusack, Victoria Goss, Anthony D. Postle, & Michael P. W. Grocott. (2012). Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?. Critical Care. 16(6). 238–238. 77 indexed citations
19.
Dushianthan, Ahilanandan, et al.. (2010). Multiple pulmonary micronodules in a patient with Crohn's disease. BMJ Case Reports. 2010. bcr0120102666–bcr0120102666. 1 indexed citations
20.
Dushianthan, Ahilanandan. (2009). Safety and effectiveness of home-based pulmonary rehabilitation in COPD. Thorax. 64(7). 619–619. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026